SOFIA (Bulgaria), August 29 (SeeNews) -Â Bulgarian drug maker Sopharma [BUL:3JR] said on Tuesday that its consolidated net profit excluding minority interest rose to 22.6 million levs ($12.8 million/11.6 million euro) in the first half of 2019 from 20.7 million levs in the same period of 2018.